Global and China Drug Eluting Implant Market Insights, Forecast to 2027

Global and China Drug Eluting Implant Market Insights, Forecast to 2027

  • QYResearch
  • November 2021
  • Medical Equipments
  • 150 pages
1 Study Coverage
1.1 Drug Eluting Implant Product Introduction
1.2 Market by Type
1.2.1 Global Drug Eluting Implant Market Size Growth Rate by Type
1.2.2 Rapamycin Eluting Implant
1.2.3 Paclitaxel Eluting Implant
1.2.4 Everolimus Eluting Implant
1.2.5 Others
1.3 Market by Application
1.3.1 Global Drug Eluting Implant Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Drug Eluting Implant Market Size, Estimates and Forecasts
2.1.1 Global Drug Eluting Implant Revenue 2016-2027
2.1.2 Global Drug Eluting Implant Sales 2016-2027
2.2 Global Drug Eluting Implant, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Drug Eluting Implant Historical Market Size by Region (2016-2021)
2.3.1 Global Drug Eluting Implant Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Drug Eluting Implant Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Drug Eluting Implant Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Drug Eluting Implant Sales Forecast by Region (2022-2027)
2.4.2 Global Drug Eluting Implant Revenue Forecast by Region (2022-2027)

3 Global Drug Eluting Implant Competitor Landscape by Players
3.1 Global Top Drug Eluting Implant Manufacturers by Sales
3.1.1 Global Drug Eluting Implant Sales by Manufacturer (2016-2021)
3.1.2 Global Drug Eluting Implant Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Drug Eluting Implant Manufacturers by Revenue
3.2.1 Key Drug Eluting Implant Manufacturers Covered: Ranking by Revenue
3.2.2 Global Drug Eluting Implant Revenue by Manufacturers (2016-2021)
3.2.3 Global Drug Eluting Implant Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Drug Eluting Implant Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Drug Eluting Implant Revenue in 2020
3.2.6 Global Drug Eluting Implant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Drug Eluting Implant Price by Manufacturers
3.4 Global Drug Eluting Implant Manufacturing Base Distribution, Product Types
3.4.1 Drug Eluting Implant Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Drug Eluting Implant Product Type
3.4.3 Date of International Manufacturers Enter into Drug Eluting Implant Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Drug Eluting Implant Market Size by Type (2016-2021)
4.1.1 Global Drug Eluting Implant Sales by Type (2016-2021)
4.1.2 Global Drug Eluting Implant Revenue by Type (2016-2021)
4.1.3 Drug Eluting Implant Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Drug Eluting Implant Market Size Forecast by Type (2022-2027)
4.2.1 Global Drug Eluting Implant Sales Forecast by Type (2022-2027)
4.2.2 Global Drug Eluting Implant Revenue Forecast by Type (2022-2027)
4.2.3 Drug Eluting Implant Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Drug Eluting Implant Market Size by Application (2016-2021)
5.1.1 Global Drug Eluting Implant Sales by Application (2016-2021)
5.1.2 Global Drug Eluting Implant Revenue by Application (2016-2021)
5.1.3 Drug Eluting Implant Price by Application (2016-2021)
5.2 Drug Eluting Implant Market Size Forecast by Application (2022-2027)
5.2.1 Global Drug Eluting Implant Sales Forecast by Application (2022-2027)
5.2.2 Global Drug Eluting Implant Revenue Forecast by Application (2022-2027)
5.2.3 Global Drug Eluting Implant Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Drug Eluting Implant Market Size YoY Growth 2016-2027
6.1.1 China Drug Eluting Implant Sales YoY Growth 2016-2027
6.1.2 China Drug Eluting Implant Revenue YoY Growth 2016-2027
6.1.3 China Drug Eluting Implant Market Share in Global Market 2016-2027
6.2 China Drug Eluting Implant Market Size by Players (International and Local Players)
6.2.1 China Top Drug Eluting Implant Players by Sales (2016-2021)
6.2.2 China Top Drug Eluting Implant Players by Revenue (2016-2021)
6.3 China Drug Eluting Implant Historic Market Review by Type (2016-2021)
6.3.1 China Drug Eluting Implant Sales Market Share by Type (2016-2021)
6.3.2 China Drug Eluting Implant Revenue Market Share by Type (2016-2021)
6.3.3 China Drug Eluting Implant Price by Type (2016-2021)
6.4 China Drug Eluting Implant Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Drug Eluting Implant Sales Forecast by Type (2022-2027)
6.4.2 China Drug Eluting Implant Revenue Forecast by Type (2022-2027)
6.4.3 China Drug Eluting Implant Price Forecast by Type (2022-2027)
6.5 China Drug Eluting Implant Historic Market Review by Application (2016-2021)
6.5.1 China Drug Eluting Implant Sales Market Share by Application (2016-2021)
6.5.2 China Drug Eluting Implant Revenue Market Share by Application (2016-2021)
6.5.3 China Drug Eluting Implant Price by Application (2016-2021)
6.6 China Drug Eluting Implant Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Drug Eluting Implant Sales Forecast by Application (2022-2027)
6.6.2 China Drug Eluting Implant Revenue Forecast by Application (2022-2027)
6.6.3 China Drug Eluting Implant Price Forecast by Application (2022-2027)

7 North America
7.1 North America Drug Eluting Implant Market Size YoY Growth 2016-2027
7.2 North America Drug Eluting Implant Market Facts & Figures by Country
7.2.1 North America Drug Eluting Implant Sales by Country (2016-2021)
7.2.2 North America Drug Eluting Implant Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Drug Eluting Implant Market Size YoY Growth 2016-2027
8.2 Asia Pacific Drug Eluting Implant Market Facts & Figures by Region
8.2.1 Asia Pacific Drug Eluting Implant Sales by Region (2016-2021)
8.2.2 Asia Pacific Drug Eluting Implant Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia

9 Europe
9.1 Europe Drug Eluting Implant Market Size YoY Growth 2016-2027
9.2 Europe Drug Eluting Implant Market Facts & Figures by Country
9.2.1 Europe Drug Eluting Implant Sales by Country (2016-2021)
9.2.2 Europe Drug Eluting Implant Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Drug Eluting Implant Market Size YoY Growth 2016-2027
10.2 Latin America Drug Eluting Implant Market Facts & Figures by Country
10.2.1 Latin America Drug Eluting Implant Sales by Country (2016-2021)
10.2.2 Latin America Drug Eluting Implant Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
10.2.6 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Drug Eluting Implant Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Drug Eluting Implant Market Facts & Figures by Country
11.2.1 Middle East and Africa Drug Eluting Implant Sales by Country (2016-2021)
11.2.2 Middle East and Africa Drug Eluting Implant Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Boston Scientific
12.1.1 Boston Scientific Corporation Information
12.1.2 Boston Scientific Description and Business Overview
12.1.3 Boston Scientific Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Boston Scientific Drug Eluting Implant Products Offered
12.1.5 Boston Scientific Recent Development
12.2 Medtronic
12.2.1 Medtronic Corporation Information
12.2.2 Medtronic Description and Business Overview
12.2.3 Medtronic Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Medtronic Drug Eluting Implant Products Offered
12.2.5 Medtronic Recent Development
12.3 Abbott
12.3.1 Abbott Corporation Information
12.3.2 Abbott Description and Business Overview
12.3.3 Abbott Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Abbott Drug Eluting Implant Products Offered
12.3.5 Abbott Recent Development
12.4 Lepu Medical
12.4.1 Lepu Medical Corporation Information
12.4.2 Lepu Medical Description and Business Overview
12.4.3 Lepu Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Lepu Medical Drug Eluting Implant Products Offered
12.4.5 Lepu Medical Recent Development
12.5 B. Braun Melsungen
12.5.1 B. Braun Melsungen Corporation Information
12.5.2 B. Braun Melsungen Description and Business Overview
12.5.3 B. Braun Melsungen Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
12.5.4 B. Braun Melsungen Drug Eluting Implant Products Offered
12.5.5 B. Braun Melsungen Recent Development
12.6 MicroPort Scientific
12.6.1 MicroPort Scientific Corporation Information
12.6.2 MicroPort Scientific Description and Business Overview
12.6.3 MicroPort Scientific Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
12.6.4 MicroPort Scientific Drug Eluting Implant Products Offered
12.6.5 MicroPort Scientific Recent Development
12.7 Cook Medical
12.7.1 Cook Medical Corporation Information
12.7.2 Cook Medical Description and Business Overview
12.7.3 Cook Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Cook Medical Drug Eluting Implant Products Offered
12.7.5 Cook Medical Recent Development
12.8 Terumo
12.8.1 Terumo Corporation Information
12.8.2 Terumo Description and Business Overview
12.8.3 Terumo Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Terumo Drug Eluting Implant Products Offered
12.8.5 Terumo Recent Development
12.9 Biosensors International
12.9.1 Biosensors International Corporation Information
12.9.2 Biosensors International Description and Business Overview
12.9.3 Biosensors International Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Biosensors International Drug Eluting Implant Products Offered
12.9.5 Biosensors International Recent Development
12.10 Balton
12.10.1 Balton Corporation Information
12.10.2 Balton Description and Business Overview
12.10.3 Balton Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Balton Drug Eluting Implant Products Offered
12.10.5 Balton Recent Development
12.11 Boston Scientific
12.11.1 Boston Scientific Corporation Information
12.11.2 Boston Scientific Description and Business Overview
12.11.3 Boston Scientific Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Boston Scientific Drug Eluting Implant Products Offered
12.11.5 Boston Scientific Recent Development
12.12 Biotronik
12.12.1 Biotronik Corporation Information
12.12.2 Biotronik Description and Business Overview
12.12.3 Biotronik Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Biotronik Products Offered
12.12.5 Biotronik Recent Development
12.13 Shandong JW Medical
12.13.1 Shandong JW Medical Corporation Information
12.13.2 Shandong JW Medical Description and Business Overview
12.13.3 Shandong JW Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Shandong JW Medical Products Offered
12.13.5 Shandong JW Medical Recent Development
12.14 Sino Medical
12.14.1 Sino Medical Corporation Information
12.14.2 Sino Medical Description and Business Overview
12.14.3 Sino Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Sino Medical Products Offered
12.14.5 Sino Medical Recent Development
12.15 Beijing AMSINO
12.15.1 Beijing AMSINO Corporation Information
12.15.2 Beijing AMSINO Description and Business Overview
12.15.3 Beijing AMSINO Drug Eluting Implant Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Beijing AMSINO Products Offered
12.15.5 Beijing AMSINO Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Drug Eluting Implant Industry Trends
13.2 Drug Eluting Implant Market Drivers
13.3 Drug Eluting Implant Market Challenges
13.4 Drug Eluting Implant Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Drug Eluting Implant Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Drug Eluting Implant Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Rapamycin Eluting Implant
Table 3. Major Manufacturers of Paclitaxel Eluting Implant
Table 4. Major Manufacturers of Everolimus Eluting Implant
Table 5. Major Manufacturers of Others
Table 6. Global Drug Eluting Implant Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 7. Global Drug Eluting Implant Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Drug Eluting Implant Sales by Regions (2016-2021) & (K Units)
Table 9. Global Drug Eluting Implant Sales Market Share by Regions (2016-2021)
Table 10. Global Drug Eluting Implant Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Drug Eluting Implant Sales Forecast by Region (2022-2027) & (K Units)
Table 12. Global Drug Eluting Implant Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Drug Eluting Implant Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Drug Eluting Implant Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Drug Eluting Implant Sales by Manufacturers (2016-2021) (K Units)
Table 16. Global Drug Eluting Implant Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Drug Eluting Implant Manufacturers by Revenue (US$ Million) in 2020
Table 18. Drug Eluting Implant Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Drug Eluting Implant Revenue Share by Manufacturers (2016-2021)
Table 20. Global Drug Eluting Implant Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Drug Eluting Implant by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Eluting Implant as of 2020)
Table 22. Key Manufacturers Drug Eluting Implant Price (2016-2021) (US$/Unit)
Table 23. Drug Eluting Implant Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Drug Eluting Implant Product Type
Table 25. Date of International Manufacturers Enter into Drug Eluting Implant Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Drug Eluting Implant Sales by Type (2016-2021) (K Units)
Table 28. Global Drug Eluting Implant Sales Share by Type (2016-2021)
Table 29. Global Drug Eluting Implant Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Drug Eluting Implant Revenue Share by Type (2016-2021)
Table 31. Drug Eluting Implant Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 32. Global Drug Eluting Implant Sales Forecast by Type (2022-2027) & (K Units)
Table 33. Global Drug Eluting Implant Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Drug Eluting Implant Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Drug Eluting Implant Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Drug Eluting Implant Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 37. Global Drug Eluting Implant Sales by Application (2016-2021) (K Units)
Table 38. Global Drug Eluting Implant Sales Share by Application (2016-2021)
Table 39. Global Drug Eluting Implant Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Drug Eluting Implant Revenue Share by Application (2016-2021)
Table 41. Drug Eluting Implant Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 42. Global Drug Eluting Implant Sales Forecast by Application (2022-2027) & (K Units)
Table 43. Global Drug Eluting Implant Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Drug Eluting Implant Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Drug Eluting Implant Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Drug Eluting Implant Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 47. China Drug Eluting Implant Sales (K Units) of Key Companies (2016-2021)
Table 48. China Drug Eluting Implant Sales Share by Company (2016-2021)
Table 49. China Drug Eluting Implant Revenue (US$ Million) by Company (2016-2021)
Table 50. China Drug Eluting Implant Revenue Share by Company (2016-2021)
Table 51. China Drug Eluting Implant Sales (K Units) by Type (2016-2021)
Table 52. China Drug Eluting Implant Sales Share by Type (2016-2021)
Table 53. China Drug Eluting Implant Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. China Drug Eluting Implant Price (US$/Unit) by Type (2016-2021)
Table 55. China Drug Eluting Implant Sales (K Units) by Type (2022-2027)
Table 56. China Drug Eluting Implant Sales Share by Type (2022-2027)
Table 57. China Drug Eluting Implant Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. China Drug Eluting Implant Revenue Share by Type (2022-2027)
Table 59. China Drug Eluting Implant Price (US$/Unit) by Type (2022-2027)
Table 60. China Drug Eluting Implant Sales (K Units) by Application (2016-2021)
Table 61. China Drug Eluting Implant Sales Share by Application (2016-2021)
Table 62. China Drug Eluting Implant Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. China Drug Eluting Implant Price (US$/Unit) by Application (2016-2021)
Table 64. China Drug Eluting Implant Sales (K Units) by Application (2022-2027)
Table 65. China Drug Eluting Implant Sales Share by Application (2022-2027)
Table 66. China Drug Eluting Implant Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. China Drug Eluting Implant Revenue Share by Application (2022-2027)
Table 68. China Drug Eluting Implant Price (US$/Unit) by Application (2022-2027)
Table 69. North America Drug Eluting Implant Sales by Country (2016-2021) & (K Units)
Table 70. North America Drug Eluting Implant Sales Market Share by Country (2016-2021)
Table 71. North America Drug Eluting Implant Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Drug Eluting Implant Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Drug Eluting Implant Sales by Region (2016-2021) & (K Units)
Table 74. Asia Pacific Drug Eluting Implant Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Drug Eluting Implant Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Drug Eluting Implant Revenue Market Share by Region (2016-2021)
Table 77. Europe Drug Eluting Implant Sales by Country (2016-2021) & (K Units)
Table 78. Europe Drug Eluting Implant Sales Market Share by Country (2016-2021)
Table 79. Europe Drug Eluting Implant Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Drug Eluting Implant Revenue Market Share by Country (2016-2021)
Table 81. Latin America Drug Eluting Implant Sales by Country (2016-2021) & (K Units)
Table 82. Latin America Drug Eluting Implant Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Drug Eluting Implant Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Drug Eluting Implant Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Drug Eluting Implant Sales by Country (2016-2021) & (K Units)
Table 86. Middle East and Africa Drug Eluting Implant Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Drug Eluting Implant Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Drug Eluting Implant Revenue Market Share by Country (2016-2021)
Table 89. Boston Scientific Corporation Information
Table 90. Boston Scientific Description and Business Overview
Table 91. Boston Scientific Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 92. Boston Scientific Drug Eluting Implant Product
Table 93. Boston Scientific Recent Development
Table 94. Medtronic Corporation Information
Table 95. Medtronic Description and Business Overview
Table 96. Medtronic Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 97. Medtronic Product
Table 98. Medtronic Recent Development
Table 99. Abbott Corporation Information
Table 100. Abbott Description and Business Overview
Table 101. Abbott Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 102. Abbott Product
Table 103. Abbott Recent Development
Table 104. Lepu Medical Corporation Information
Table 105. Lepu Medical Description and Business Overview
Table 106. Lepu Medical Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 107. Lepu Medical Product
Table 108. Lepu Medical Recent Development
Table 109. B. Braun Melsungen Corporation Information
Table 110. B. Braun Melsungen Description and Business Overview
Table 111. B. Braun Melsungen Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 112. B. Braun Melsungen Product
Table 113. B. Braun Melsungen Recent Development
Table 114. MicroPort Scientific Corporation Information
Table 115. MicroPort Scientific Description and Business Overview
Table 116. MicroPort Scientific Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 117. MicroPort Scientific Product
Table 118. MicroPort Scientific Recent Development
Table 119. Cook Medical Corporation Information
Table 120. Cook Medical Description and Business Overview
Table 121. Cook Medical Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 122. Cook Medical Product
Table 123. Cook Medical Recent Development
Table 124. Terumo Corporation Information
Table 125. Terumo Description and Business Overview
Table 126. Terumo Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 127. Terumo Product
Table 128. Terumo Recent Development
Table 129. Biosensors International Corporation Information
Table 130. Biosensors International Description and Business Overview
Table 131. Biosensors International Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 132. Biosensors International Product
Table 133. Biosensors International Recent Development
Table 134. Balton Corporation Information
Table 135. Balton Description and Business Overview
Table 136. Balton Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 137. Balton Product
Table 138. Balton Recent Development
Table 139. AlviMedica Medical Technologies Corporation Information
Table 140. AlviMedica Medical Technologies Description and Business Overview
Table 141. AlviMedica Medical Technologies Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 142. AlviMedica Medical Technologies Product
Table 143. AlviMedica Medical Technologies Recent Development
Table 144. Biotronik Corporation Information
Table 145. Biotronik Description and Business Overview
Table 146. Biotronik Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Biotronik Product
Table 148. Biotronik Recent Development
Table 149. Shandong JW Medical Corporation Information
Table 150. Shandong JW Medical Description and Business Overview
Table 151. Shandong JW Medical Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 152. Shandong JW Medical Product
Table 153. Shandong JW Medical Recent Development
Table 154. Sino Medical Corporation Information
Table 155. Sino Medical Description and Business Overview
Table 156. Sino Medical Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 157. Sino Medical Product
Table 158. Sino Medical Recent Development
Table 159. Beijing AMSINO Corporation Information
Table 160. Beijing AMSINO Description and Business Overview
Table 161. Beijing AMSINO Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 162. Beijing AMSINO Product
Table 163. Beijing AMSINO Recent Development
Table 164. Drug Eluting Implant Market Trends
Table 165. Drug Eluting Implant Market Drivers
Table 166. Drug Eluting Implant Market Challenges
Table 167. Drug Eluting Implant Market Restraints
Table 168. Drug Eluting Implant Customers List
Table 169. Drug Eluting Implant Distributors List
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Eluting Implant Product Picture
Figure 2. Global Drug Eluting Implant Sales Market Share by Type in 2020 & 2027
Figure 3. Rapamycin Eluting Implant Product Picture
Figure 4. Paclitaxel Eluting Implant Product Picture
Figure 5. Everolimus Eluting Implant Product Picture
Figure 6. Others Product Picture
Figure 7. Global Drug Eluting Implant Sales Market Share by Application in 2020 & 2027
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Ambulatory Surgical Centers
Figure 11. Others
Figure 12. Drug Eluting Implant Report Years Considered
Figure 13. Global Drug Eluting Implant Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Drug Eluting Implant Market Size 2016-2027 (US$ Million)
Figure 15. Global Drug Eluting Implant Sales 2016-2027 (K Units)
Figure 16. Global Drug Eluting Implant Market Size Market Share by Region: 2021 Versus 2027
Figure 17. Global Drug Eluting Implant Sales Market Share by Region (2016-2021)
Figure 18. Global Drug Eluting Implant Sales Market Share by Region in 2020
Figure 19. Global Drug Eluting Implant Revenue Market Share by Region (2016-2021)
Figure 20. Global Drug Eluting Implant Revenue Market Share by Region in 2020
Figure 21. Global Drug Eluting Implant Sales Share by Manufacturer in 2020
Figure 22. The Top 10 and 5 Players Market Share by Drug Eluting Implant Revenue in 2020
Figure 23. Drug Eluting Implant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 24. Global Drug Eluting Implant Sales Market Share by Type (2016-2021)
Figure 25. Global Drug Eluting Implant Sales Market Share by Type in 2020
Figure 26. Global Drug Eluting Implant Revenue Market Share by Type (2016-2021)
Figure 27. Global Drug Eluting Implant Revenue Market Share by Type in 2020
Figure 28. Global Drug Eluting Implant Sales Market Share by Application (2016-2021)
Figure 29. Global Drug Eluting Implant Sales Market Share by Application in 2020
Figure 30. Global Drug Eluting Implant Revenue Market Share by Application (2016-2021)
Figure 31. Global Drug Eluting Implant Revenue Market Share by Application in 2020
Figure 32. China Drug Eluting Implant Sales Growth Rate 2016-2027 (K Units)
Figure 33. China Drug Eluting Implant Revenue Growth Rate 2016-2027 (US$ Million)
Figure 34. China Drug Eluting Implant Market Share in Global Market 2016-2027
Figure 35. China 5 and 10 Largest Drug Eluting Implant Players Market Share by Revenue in Drug Eluting Implant in 2020
Figure 36. China Drug Eluting Implant Revenue Share by Type (2016-2021)
Figure 37. China Drug Eluting Implant Revenue Growth Rate by Type in 2016 & 2020
Figure 38. China Drug Eluting Implant Revenue Share by Application (2016-2021)
Figure 39. China Drug Eluting Implant Revenue Growth Rate by Application in 2016 & 2020
Figure 40. North America Drug Eluting Implant Sales Growth Rate 2016-2021 (K Units)
Figure 41. North America Drug Eluting Implant Revenue Growth Rate 2016-2021 (US$ Million)
Figure 42. North America Drug Eluting Implant Sales Market Share by Country in 2020
Figure 43. North America Drug Eluting Implant Revenue Market Share by Country in 2020
Figure 44. United States Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 45. United States Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Canada Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 47. Canada Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Europe Drug Eluting Implant Sales Growth Rate 2016-2021 (K Units)
Figure 49. Europe Drug Eluting Implant Revenue Growth Rate 2016-2021 (US$ Million)
Figure 50. Europe Drug Eluting Implant Sales Market Share by Country in 2020
Figure 51. Europe Drug Eluting Implant Revenue Market Share by Country in 2020
Figure 52. Germany Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 53. Germany Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. France Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 55. France Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. U.K. Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 57. U.K. Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Italy Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 59. Italy Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Russia Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 61. Russia Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Asia Pacific Drug Eluting Implant Sales Growth Rate 2016-2021 (K Units)
Figure 63. Asia Pacific Drug Eluting Implant Revenue Growth Rate 2016-2021 (US$ Million)
Figure 64. Asia Pacific Drug Eluting Implant Sales Market Share by Region in 2020
Figure 65. Asia Pacific Drug Eluting Implant Revenue Market Share by Region in 2020
Figure 66. China Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 67. China Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. Japan Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 69. Japan Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. South Korea Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 71. South Korea Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. India Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 73. India Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Australia Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 75. Australia Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. China Taiwan Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 77. China Taiwan Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Indonesia Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 79. Indonesia Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Thailand Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 81. Thailand Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Malaysia Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 83. Malaysia Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Latin America Drug Eluting Implant Sales Growth Rate 2016-2021 (K Units)
Figure 85. Latin America Drug Eluting Implant Revenue Growth Rate 2016-2021 (US$ Million)
Figure 86. Latin America Drug Eluting Implant Sales Market Share by Country in 2020
Figure 87. Latin America Drug Eluting Implant Revenue Market Share by Country in 2020
Figure 88. Mexico Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 89. Mexico Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Brazil Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 91. Brazil Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Argentina Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 93. Argentina Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Colombia Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 95. Colombia Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Middle East and Africa Drug Eluting Implant Sales Growth Rate 2016-2021 (K Units)
Figure 97. Middle East and Africa Drug Eluting Implant Revenue Growth Rate 2016-2021 (US$ Million)
Figure 98. Middle East and Africa Drug Eluting Implant Sales Market Share by Country in 2020
Figure 99. Middle East and Africa Drug Eluting Implant Revenue Market Share by Country in 2020
Figure 100. Turkey Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 101. Turkey Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Saudi Arabia Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 103. Saudi Arabia Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. UAE Drug Eluting Implant Sales Growth Rate (2016-2021) (K Units)
Figure 105. UAE Drug Eluting Implant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Drug Eluting Implant Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed

Have query on this report?

Success Stories

Our Clients